Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
9.40
+0.68 (7.80%)
At close: Jun 22, 2026, 4:00 PM EDT
9.59
+0.19 (2.02%)
After-hours: Jun 22, 2026, 6:06 PM EDT
Immix Biopharma Employees
As of December 31, 2025, Immix Biopharma had 21 total employees, including 18 full-time and 3 part-time employees. The number of employees did not change compared to the previous year.
Employees
21
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,665,846
Market Cap
669.19M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | 0 | - | 21 | 0 |
| Dec 31, 2024 | 21 | 4 | 23.53% | 18 | 3 |
| Dec 31, 2023 | 17 | 6 | 54.55% | 14 | 3 |
| Dec 31, 2022 | 11 | 9 | 450.00% | 9 | 2 |
| Dec 31, 2021 | 2 | - | - | 2 | 0 |
| Sep 30, 2021 | 2 | - | - | 2 | 0 |
| Jun 30, 2021 | 2 | - | - | 2 | 0 |
Related Stocks
Employee RankingsIMMX News
- 4 days ago - Immix Biopharma initiated with a Buy at BofA - TheFly
- 5 days ago - Immix Biopharma initiated with an Outperform at LifeSci Capital - TheFly
- 5 days ago - Immix Biopharma Slides: Corporate presentation - Filings
- 4 weeks ago - Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 4 weeks ago - Immix Biopharma price target raised to $20 from $15 at H.C. Wainwright - TheFly
- 4 weeks ago - Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 4 weeks ago - Immix Biopharma’s NXC-201 reaches 95% complete response rate in AL amyloidosis - TheFly
- 4 weeks ago - Immix Biopharma Announces 95% Complete Response Rate in Interim Update From relapsed/refractory AL Amyloidosis Clinical Trial NEXICART-2 - GlobeNewsWire